Science Explorer Back to mapMap

Most cited papers from Bavarian Nordic (Germany)

What are the most cited papers from Bavarian Nordic (Germany)?

The most cited paper from Bavarian Nordic (Germany) is "The changing epidemiology of human monkeypox—A potential threat? A systematic review" (Eveline M. Bunge, Bernard Hoet, Liddy M. Chen et al., 2022), with 1,977 citations. Next come "Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo" (817) and "Quantitative Proteomics Reveals Subset-Specific Viral Recognition in Dendritic Cells" (589).

Showing 50 of 59 papers. Every paper with more than 68 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The changing epidemiology of human monkeypox—A potential threat? A systematic review Eveline M. Bunge, Bernard Hoet, Liddy M. Chen et al. · PLoS neglected tropical diseases ReviewOpen access 11 Feb 2022 1,977
2 Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo Shalin H. Naik, Priyanka Sathe, Hae‐Young Park et al. · Nature Immunology 7 Oct 2007 817
3 Quantitative Proteomics Reveals Subset-Specific Viral Recognition in Dendritic Cells Christian A. Luber, Jürgen Cox, Henning Lauterbach et al. · Immunity Open access Feb 2010 589
4 Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures Shalin H. Naik, Anna I. Proietto, Nicholas S. Wilson et al. · The Journal of Immunology Jun 2005 544
5 TLR13 Recognizes Bacterial 23 S rRNA Devoid of Erythromycin Resistance–Forming Modification Marina Oldenburg, Anne Krüger, Ruth Ferstl et al. · Science 24 Jul 2012 412
6 A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA Katie Ewer et al. · New England Journal of Medicine Open access 28 Jan 2015 357
7 Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines Iain D. Milligan et al. · JAMA 19 Apr 2016 331
8 Human monkeypox – After 40 years, an unintended consequence of smallpox eradication Karl Simpson et al. · Vaccine Open access 13 May 2020 327
9 The interleukin-10 family of cytokines Helmut Fickenscher, Simon Hör, Heide Küpers et al. · Trends in Immunology Review Feb 2002 327
10 Infrared-spectroscopic nanoimaging with a thermal source Florian Huth, Martin Schnell, Jesper Wittborn et al. · Nature Materials 17 Apr 2011 306
11 Brain IGF-1 Receptors Control Mammalian Growth and Lifespan through a Neuroendocrine Mechanism Laurent Kappeler, Carlos De Magalhaes Filho, Joëlle Dupont et al. · PLoS Biology Open access 24 Oct 2008 293
12 SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma Christoph Kneip, Bernd Schmidt, Anke Seegebarth et al. · Journal of Thoracic Oncology Open access 21 Jun 2011 279
13 Mouse CD8α+ DCs and human BDCA3+ DCs are major producers of IFN-λ in response to poly IC Henning Lauterbach, Barbara Bathke, Stefanie Gilles et al. · The Journal of Experimental Medicine Open access 25 Oct 2010 270
14 Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox Phillip R. Pittman, Matthew W. Hahn, HeeChoon S. Lee et al. · New England Journal of Medicine Open access 13 Nov 2019 262
15 Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. Ingo Drexler, Britta Wahrén, Gerd Sutter et al. · Journal of General Virology Feb 1998 244
16 Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus Koert J. Stittelaar, Geert van Amerongen, Ivanela I. Kondova et al. · Journal of Virology Open access 26 May 2005 235
17 Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. Michael Wachinger, R Brack-Werner, Volker Erfle et al. · Journal of General Virology Apr 1998 226
18 Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma Matthias J. Löhr, Anne Hoffmeyer, Jens‐Christian Kröger et al. · The Lancet May 2001 211
19 SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates Bernd Schmidt, Volker Liebenberg, Dimo Dietrich et al. · BMC Cancer Open access 3 Nov 2010 208
20 Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: Influence of mismatches on quantification Dieter Klein, Petra Janda, Ralf Steinborn et al. · Electrophoresis Feb 1999 188
21 Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine Jens Vollmar, Nathaly Arndtz, Karl M. Eckl et al. · Vaccine 29 Nov 2005 177
22 Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy Ryan B. Rountree, Stefanie J. Mandl, James M. Nachtwey et al. · Cancer Research Open access 13 Jun 2011 160
23 Phenotype and function of neonatal DC Fabienne Willems, Sabine Vollstedt, Mark Suter · European Journal of Immunology 2009 160
24 In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation Björn‐Erik Ole Jensen et al. · Nature Medicine Open access 20 Feb 2023 157
25 Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells David Vremec, Meredith A O’Keeffe, Hubertus Hochrein et al. · Blood Open access 12 Oct 2006 156
26 PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing Amanda Lee Gavin et al. · Nature Immunology Open access 13 Aug 2018 153
27 Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects Sharon E. Frey et al. · Vaccine Open access 4 Jul 2015 151
28 Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial Edgar Turner Overton, Jack T. Stapleton, Ian Frank et al. · Open Forum Infectious Diseases Open access 2015 143
29 Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection Christofer Samuelsson, Jürgen Hausmann, Henning Lauterbach et al. · Journal of Clinical Investigation Open access 15 Apr 2008 141
30 Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects Richard Neil Greenberg, Edgar Turner Overton, David W. Haas et al. · The Journal of Infectious Diseases Open access 7 Dec 2012 136
31 A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE® Alfred von Krempelhuber, Jens Vollmar, Rolf Pokorny et al. · Vaccine Open access 27 Nov 2009 124
32 Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells Irina Caminschi, Fatma Ahmet, Klaus Heger et al. · The Journal of Experimental Medicine Open access 8 Oct 2007 121
33 A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis Richard Neil Greenberg, Yadira M. Hurley, Dinh V. Dinh et al. · PLoS ONE Open access 6 Oct 2015 115
34 Monte Carlo simulation of the Spearman-Kaerber TCID50 Niels Wulff, Maria Tzatzaris, Philip J. Young · Journal of Clinical Bioinformatics Open access 2012 112
35 Antibiotic treatment–induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia Oliver Robak et al. · Journal of Clinical Investigation Open access 17 May 2018 110
36 M-CSF: a novel plasmacytoid and conventional dendritic cell poietin Ben Fancke, Mark Suter, Hubertus Hochrein et al. · Blood 4 Oct 2007 110
37 Expression of Antimicrobial Peptides Has an Antitumour Effect in Human Cells David M. Winder, Walter Henry Gunzburg, Volker Erfle et al. · Biochemical and Biophysical Research Communications 1998 107
38 Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 Nef -Expressing Mva: Safety, Immunogenicity and Influence on Viral Load during Treatment Interruption Ellen G. Harrer, Michael Bäuerle, Barbara Ferstl et al. · Antiviral Therapy Open access Feb 2005 104
39 Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9‐dependent maturation and IFN‐α production Etiena Basner‐Tschakarjan, Evelyn Gaffal, Meredith A O’Keeffe et al. · The Journal of Gene Medicine Open access 4 Sep 2006 103
40 Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA Anne Krüger, Marina Oldenburg, Chiranjeevi Chebrolu et al. · EMBO Reports Open access 6 Nov 2015 100
41 Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450 Matthias J. Löhr, Petra Müller, Peter Karle et al. · Gene Therapy Aug 1998 98
42 A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates Benoît Callendret et al. · PLoS ONE Open access 20 Feb 2018 94
43 CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation Itziar Otano et al. · Nature Communications Open access 15 Dec 2021 93
44 Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial Jason S. Richardson, Deborah M. Anderson, Jason Mendy et al. · The Lancet 30 Mar 2025 90
45 Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above Desmond Curran, Ruprecht Schmidt‐Ott, Ulf Schutter et al. · BMC Infectious Diseases Open access 3 Oct 2018 87
46 Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara Christine Meisinger-Henschel, Michaela Schmidt, Susanne Lukassen et al. · Journal of General Virology 17 Nov 2007 86
47 Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination Massimo Di Nicola, Carmelo Carlo‐Stella, Roberta Mortarini et al. · Clinical Cancer Research 15 Aug 2004 83
48 A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects Richard Neil Greenberg, Christine Mhorag Hay, Jack T. Stapleton et al. · PLoS ONE Open access 21 Jun 2016 82
49 The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells Sonja Mandl–Weber, Felix G. Meinel, Rüdiger Jankowsky et al. · British Journal of Haematology Open access Mar 2010 81
50 Influence of Preassay and Sequence Variations on Viral Load Determination by a Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction for Feline Immunodeficiency Virus Dieter Klein, Christian M. Leutenegger, Claudia Bahula et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes 2001 80

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.